Helius Medical Technologies, Inc.
642 Newtown Yardley Road, Suite 100
Newtown, PA 18940
| February 4, 2020 | VIA EDGAR |
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Chris Edwards
| RE: | Helius Medical Technologies, Inc. | |||||
| Registration Statement on FormS-3 | ||||||
| FileNo. 333-236101 | ||||||
| Acceleration Request | ||||||
| Requested Date: | February 6, 2020 | |||||
| Requested Time: | 4:00 P.M. Eastern Time | |||||
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on FormS-3 (the “Registration Statement”) to become effective on February 6, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Owen Williams, counsel to the Registrant,at (202) 842-7843.
Very truly yours,
Helius Medical Technologies, Inc.
/s/ Joyce LaViscount | ||
| Joyce LaViscount | ||
| Chief Financial Officer and Chief Operating Officer | ||
| cc: | Philippe Deschamps, President and Chief Executive Officer | |
| Darren K. DeStefano, Cooley LLP | ||
| Jeffrey Libson, Cooley LLP | ||
